Agency Information Collection Activities: Submission for OMB Review; Comment Request, 52917 [2021-20608]
Download as PDF
<![CDATA[
52917
Federal Register / Vol. 86, No. 182 / Thursday, September 23, 2021 / Notices
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Trinh T. Tran, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827–5843, trinh.tran@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
Animal Genomics Program (U01—Clinical
Trial Not Allowed).
Date: November 5, 2021.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Ipolia R. Ramadan, Ph.D.,
Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827–4471, ramadanir@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Assessing the Effects of Cannabinoids on
HIV-Associated Persistent Inflammation (R01
Clinical Trial Optional).
Date: November 19, 2021.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: September 17, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–20581 Filed 9–22–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0361.
Proposed Project: Division of State
Programs—Management Reporting
Tool (DSP–MRT)
(OMB No. 0930–0354)—Revision
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Substance Abuse
Prevention (CSAP) aims to monitor
several substance use prevention
programs through the DSP–MRT, which
reports data using the Strategic
Prevention Framework (SPF). Programs
monitored through the DSP–MRT
include: SPF-Partnerships for Success
(PFS), SPF- Prescription Drugs (Rx),
Prescription Drug Overdose (PDO), and
First Responder-Comprehensive
Addiction and Recovery Act (FR–
CARA). SAMHSA also proposed adding
a new program: Sober Truth on
Preventing Underage Drinking Act
Grants (STOP Act). This request for data
collection includes minor revisions
from a previously approved OMB
instrument.
Monitoring data using the SPF model
will allow SAMHSA’s project officers to
systematically collect data to monitor
their grant program. In addition to
assessing activities related to the SPF
steps, the performance monitoring
instruments covered in this statement
collect data to assess the following
grantee required specific performance
measures:
• Number of training and technical
assistance activities per funded
community provided by the grantee to
support communities
• Reach of training and technical
assistance activities (numbers served)
provided by the grantee
• Percentage of subrecipient
communities that submit data to the
grantee data system
• Number of subrecipient communities
that improved on one or more targeted
National Outcome Measures
• Number of grantees who integrate
Prescription Drug Monitoring Program
data into their program needs
assessment
• Number of naloxone toolkits
distributed
Revisions to this package include the
following:
• Inclusion of six performance targets
• Removal of outdated references
• Adjustments to the language in the
Disparities Impact Section to refine
response
ANNUALIZED DATA COLLECTION BURDEN
Number of
respondents
lotter on DSK11XQN23PROD with NOTICES1
Instrument
Responses per
respondent
Total number
of responses
Total
burden
hours
Hours per
response
Average
hourly
wage
Total
respondent
cost a
DSP–MRT .....................................................
PFS Supplemental ........................................
PDO/FR CARA Supplemental ......................
SPF Rx Supplemental ...................................
STOP Act Supplemental ...............................
521
253
109
26
133
4
1
2
4
1
2,084
253
218
104
133
3
1
1
1
1
6,252
253
218
104
133
$44.19
44.19
44.19
44.19
44.19
$276,276
11,180
9,633
4,596
5,877
FY2021–FY2024 Total ...........................
521
........................
........................
........................
6,960
........................
307,562
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
VerDate Sep<11>2014
17:19 Sep 22, 2021
Jkt 253001
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
Carlos Graham,
Social Science Analyst.
[FR Doc. 2021–20608 Filed 9–22–21; 8:45 am]
BILLING CODE 4162–20–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 9990
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 86, Number 182 (Thursday, September 23, 2021)]
[Notices]
[Page 52917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-20608]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 276-0361.
Proposed Project: Division of State Programs--Management Reporting Tool
(DSP-MRT)
(OMB No. 0930-0354)--Revision
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center for Substance Abuse Prevention (CSAP) aims to monitor
several substance use prevention programs through the DSP-MRT, which
reports data using the Strategic Prevention Framework (SPF). Programs
monitored through the DSP-MRT include: SPF-Partnerships for Success
(PFS), SPF- Prescription Drugs (Rx), Prescription Drug Overdose (PDO),
and First Responder-Comprehensive Addiction and Recovery Act (FR-CARA).
SAMHSA also proposed adding a new program: Sober Truth on Preventing
Underage Drinking Act Grants (STOP Act). This request for data
collection includes minor revisions from a previously approved OMB
instrument.
Monitoring data using the SPF model will allow SAMHSA's project
officers to systematically collect data to monitor their grant program.
In addition to assessing activities related to the SPF steps, the
performance monitoring instruments covered in this statement collect
data to assess the following grantee required specific performance
measures:
Number of training and technical assistance activities per
funded community provided by the grantee to support communities
Reach of training and technical assistance activities (numbers
served) provided by the grantee
Percentage of subrecipient communities that submit data to the
grantee data system
Number of subrecipient communities that improved on one or
more targeted National Outcome Measures
Number of grantees who integrate Prescription Drug Monitoring
Program data into their program needs assessment
Number of naloxone toolkits distributed
Revisions to this package include the following:
Inclusion of six performance targets
Removal of outdated references
Adjustments to the language in the Disparities Impact Section
to refine response
Annualized Data Collection Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total
Instrument Number of Responses per Total number Hours per Total burden Average respondent
respondents respondent of responses response hours hourly wage cost \a\
--------------------------------------------------------------------------------------------------------------------------------------------------------
DSP-MRT................................. 521 4 2,084 3 6,252 $44.19 $276,276
PFS Supplemental........................ 253 1 253 1 253 44.19 11,180
PDO/FR CARA Supplemental................ 109 2 218 1 218 44.19 9,633
SPF Rx Supplemental..................... 26 4 104 1 104 44.19 4,596
STOP Act Supplemental................... 133 1 133 1 133 44.19 5,877
---------------------------------------------------------------------------------------------------------------
FY2021-FY2024 Total................. 521 .............. .............. .............. 6,960 .............. 307,562
--------------------------------------------------------------------------------------------------------------------------------------------------------
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to www.reginfo.gov/public/do/PRAMain. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.
Carlos Graham,
Social Science Analyst.
[FR Doc. 2021-20608 Filed 9-22-21; 8:45 am]
BILLING CODE 4162-20-P
